| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 25.05.
| The Law Firm of Levi & Korsinsky Notifies Investors with Losses on Their Investment in ViroPharma Incorporated of Class Action Lawsuit and the Deadline of July 17, 2012 to Seek a Lead Plaintiff Position | | 126 | Business Wire |
| Levi & Korsinsky announces that a class action lawsuit has been
commenced in the United States District Court for the Eastern District
of Pennsylvania on behalf of investors...
Mehr lesen zu:
The Law Firm of Levi & Korsinsky Notifies Investors with Losses on Their Investment in ViroPharma Incorporated of Class Action Lawsuit and the Deadline of July 17, 2012 to Seek a Lead Plaintiff Position | |
| 25.05.
| The Lin Law Firm Announces That a Securities Class Action Lawsuit Against ViroPharma Incorporated Has Been Filed | | 72 | PR Newswire |
| LOS ANGELES, May 25, 2012 /PRNewswire/ -- The Lin Law Firm, A Professional Law Corporation, announces that a class action has been filed on behalf of investors who purchased the securities of ViroPharma...
Mehr lesen zu:
The Lin Law Firm Announces That a Securities Class Action Lawsuit Against ViroPharma Incorporated Has Been Filed | |
| 24.05.
| Izard Nobel LLP Announces Class Action Lawsuit Against ViroPharma Incorporated | | 45 | MarketWire |
| WEST HARTFORD, CT -- (Marketwire) -- 05/24/12 -- The law firm of Izard Nobel LLP, which has significant experience representing investors in prosecuting claims of securities fraud, announces that a...
Mehr lesen zu:
Izard Nobel LLP Announces Class Action Lawsuit Against ViroPharma Incorporated | |
| 22.05.
| ViroPharma To Participate In Two June Healthcare Investor Conferences | | 47 | PR Newswire |
| EXTON, Pa., May 22, 2012 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that Charles Rowland, vice president and chief financial officer of ViroPharma, will present at the...
Mehr lesen zu:
ViroPharma To Participate In Two June Healthcare Investor Conferences | |
| 21.05.
| Viropharma Earnings Hindsight: Down 2.0% in Last 20 Days | | 1 | SmarTrend |
| 19.05.
| Investor Alert: Former Louisiana Attorney General and Kahn Swick & Foti, LLC, Remind Investors with Large Financial Interests of Lead Plaintiff Deadline in Class Action Lawsuit Against ViroPharma Inc. | | 152 | Business Wire |
| Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney
General of Louisiana, Charles C. Foti, Jr., remind investors that they
have until July 17, 2012, to...
Mehr lesen zu:
Investor Alert: Former Louisiana Attorney General and Kahn Swick & Foti, LLC, Remind Investors with Large Financial Interests of Lead Plaintiff Deadline in Class Action Lawsuit Against ViroPharma Inc. | |
| 18.05.
| Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against ViroPharma Incorporated | | 76 | Business Wire |
| Rigrodsky
& Long, P.A. announces that a complaint has been filed in the
United States District Court for the Eastern District of Pennsylvania on
behalf of all...
Mehr lesen zu:
Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against ViroPharma Incorporated | |
| 14.05.
| Viropharma Earnings Hindsight: Up 5.2% in Last 13 Days | | 2 | SmarTrend |
| 13.05.
| Viropharma is Among the Companies in the Pharmaceuticals Industry With the Lowest EBITDA Growth | | 3 | SmarTrend |
| 10.05.
| Bullish Moving Average Cross by Viropharma | | 3 | SmarTrend |
| 10.05.
| Viropharma Down 31.0% Since SmarTrend Downtrend Call | | - | SmarTrend |
| 03.05.
| ViroPharma Announces Upcoming Data Presentation Of Plenadren® (Hydrocortisone, Modified Release Tablet) At 2012 Joint 15th International Congress of Endocrinology and 14th European Congress of Endocrinology (ICE/ECE) | | 20 | PR Newswire |
| EXTON, Pennsylvania, May 3, 2012 /PRNewswire/ --ViroPharma Incorporated (NASDAQ: VPHM) announced three posters will be presented relating to long term data on Plenadren® (hydrocortisone, modified...
Mehr lesen zu:
ViroPharma Announces Upcoming Data Presentation Of Plenadren® (Hydrocortisone, Modified Release Tablet) At 2012 Joint 15th International Congress of Endocrinology and 14th European Congress of Endocrinology (ICE/ECE) | |
| 02.05.
| ViroPharma to Participate in Two May Healthcare Investor Conferences | | 22 | PR Newswire |
| EXTON, Pa., May 2, 2012 /PRNewswire/ --ViroPharma Incorporated (Nasdaq: VPHM) today announced that Charles Rowland, vice president and chief financial officer of ViroPharma, will present...
Mehr lesen zu:
ViroPharma to Participate in Two May Healthcare Investor Conferences | |
| 02.05.
| ViroPharma Falters, Guides Lower | | 2 | Zacks |
| 02.05.
| Downgrade Alert for Viropharma | | 9 | SmarTrend |
| 01.05.
| Bears Vindicated by ViroPharma's Plunge | | 4 | Schaeffer's Research |
| 01.05.
| ViroPharma down 11% on results | | 3 | MarketWatch |
| 01.05.
| Viropharma Crosses Below its 10-day MA | | 1 | SmarTrend |
| 01.05.
| Viropharma Shares Sinking Lower, Down 8.9% | | 3 | SmarTrend |
| 01.05.
| UPDATE 1-ViroPharma misses estimates, cuts revenue forecast | | 4 | Reuters.com |
